切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 29 -32. doi: 10.11817/j.issn.1673-9248.2020.01.005

所属专题: 专家论坛 文献

专家论坛

动脉瘤性蛛网膜下腔出血的诊断与治疗进展
王硕1,(), 马龙1, 张谦1   
  1. 1. 100070 首都医科大学附属北京天坛医院神经外科
  • 收稿日期:2019-12-16 出版日期:2020-02-01
  • 通信作者: 王硕

Diagnosis and treatment of aneurysmal subarachnoid hemorrhage

Shuo Wang1,(), Long Ma1, Qian Zhang1   

  1. 1. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
  • Received:2019-12-16 Published:2020-02-01
  • Corresponding author: Shuo Wang
  • About author:
    Corresponding author: Wang Shuo, Email:
引用本文:

王硕, 马龙, 张谦. 动脉瘤性蛛网膜下腔出血的诊断与治疗进展[J/OL]. 中华脑血管病杂志(电子版), 2020, 14(01): 29-32.

Shuo Wang, Long Ma, Qian Zhang. Diagnosis and treatment of aneurysmal subarachnoid hemorrhage[J/OL]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2020, 14(01): 29-32.

动脉瘤性蛛网膜下腔出血(aSAH)是一类致死率和致残率均非常高的出血性脑卒中。近年来,随着显微神经外科、介入神经外科等多学科的发展,aSAH的术前诊断、术中治疗及术后并发症防治方面都取得了新的进展,本综述与近期的相关研究结合,分析探讨aSAH新的诊断手段和治疗策略,并对aSAH后预防及治疗血管痉挛的药物进行综述,为临床治疗决策提供参考。

Aneurysmal subarachnoid hemorrhage (aSAH) is a type of hemorrhagic stroke with extremely high mortality and disability. In recent years, with the multidisciplinary development in micro neurosurgery and endovascular treatment, huge advances have been made in the preoperative diagnosis and treatment of aSAH. This article reviewed recent researches to analyze and explored new diagnostic methods and treatment strategies for aSAH. It would be helpful for clinical decisions.

1
Golanov EV, Bovshik EI, Wong KK, et al. Subarachnoid hemorrhage-induced block of cerebrospinal fluid flow: role of brain coagulation factor Ⅲ (tissue factor) [J]. J Cereb Blood Flow Metab, 2018, 38(5): 793-808.
2
de Oliveira Manoel AL, Mansur A, Silva GS, et al. Functional outcome after poor-grade subarachnoid hemorrhage: a single-center study and systematic literature review [J]. Neurocrit Care, 2016, 25(3): 338-350.
3
Vivancos J, Gilo F, Frutos R, et al. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment [J]. Neurologia, 2014, 29(6): 353-370.
4
Jayaraman MV, Haas RA, Do HM, et al. Should CT angiography be routinely used in patients suspected of having aneurysmal subarachnoid hemorrhage? No! [J]. Radiology, 2010, 254(1): 314.
5
Connolly ES RabinsteinJr, , Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/Am-erican Stroke Association [J]. Stroke, 2012, 43(6): 1711-1737.
6
Bechan RS, van Rooij SB, Sprengers ME, et al. CT angiography versus 3D rotational angiography in patients with subarachnoid hemorrhage [J]. Neuroradiology, 2015, 57(12): 1239-1246.
7
Westerlaan HE, van Dijk JM, Jansen-van der Weide MC, et al. Intracranial aneurysms in patients with subarachnoid hemorrhage: CT angiography as a primary examination tool for diagnosis—systematic review and meta-analysis [J]. Radiology, 2011, 258(1): 134-145.
8
Dabus G, Nogueira RG. Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature [J]. Interv Neurol, 2013, 2(1): 30-51.
9
van Lieshout JH, Dibué-Adjei M, Cornelius JF, et al. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage [J]. Neurosurg Rev, 2018, 41(4): 917-930.
10
骆众星, 李萌, 谢斯栋. 3D TOF MRA在颅内微小动脉瘤诊断中的应用效果分析 [J]. 影像研究与医学应用, 2019, 3(15): 230-231.
11
Cancelliere NM, Najafi M, Brina O, et al. 4D-CT angiography versus 3D-rotational angiography as the imaging modality for computational fluid dynamics of cerebral aneurysms [J]. J Neurointerv Surg, 2019. pii: neurintsurg-2019-015389. [Epub ahead of print]
12
Grasso G, Alafaci C, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives [J]. Surg Neurol Int, 2017, 8: 11.
13
Togashi K, Joffe AM, Sekhar L, et al. Randomized pilot trial of intensive management of blood pressure or volume expansion in subarachnoid hemorrhage (IMPROVES) [J]. Neurosurgery, 2014, 76(2): 125-135.
14
Rajajee V, Pandey AS, Williamson CA. Subarachnoid Hemorrhage and the therapy formerly known as" triple-H"-new directions [J]. World Neurosurg, 2019, 127: 500-501.
15
Dankbaar JW, Slooter AJ, Rinkel GJ, et al. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review [J]. Crit Care, 2010, 14(1): R23.
16
Harrigan MR. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm [J]. Crit Care, 2010, 14(3): 151.
17
Reynolds MR, Buckley RT, Indrakanti SS, et al. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms [J]. J Neurosurg, 2015, 123(4): 862-871.
18
Carlson AP, Hänggi D, Macdonald RL, et al. Nimodipine Reappraised: An Old Drug With a Future [J]. Curr Neuropharmacol, 2019. pii: neurintsurg-2019-015389. [Epub ahead of print]
19
Leijenaar JF, Dorhout Mees SM, Algra A, et al. Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the M agnesium in A neurysmal S ubarachnoid H aemorrhage trial (MASH‐II) [J]. Int J Stroke, 2015, 10 Suppl A100: 108-112.
20
Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial [J]. Lancet, 2012, 380(9836): 44-49.
21
Wong GKC, Poon WS, Chan MT, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH) a randomized, double-blinded, placebo-controlled, multicenter phase III trial [J]. Stroke, 2010, 41(5): 921-926.
22
van den Bergh WM, Algra A, van der Sprenkel JW, et al. Hypomagnesemia after aneurysmal subarachnoid hemorrhage [J]. Neurosurgery, 2003, 52(2): 276-282.
23
Vergouwen MD, Meijers JC, Geskus RB, et al. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial [J]. J Cereb Blood Flow Metab, 2009, 29(8): 1444-1453.
24
Wong GK, Chan DY, Siu DY, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial [J]. Stroke, 2015, 46(2): 382-388.
25
Wong GK, Chan DY, Siu DY, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial [J]. Stroke, 2015, 46(2): 382-388.
26
Macdonald RL. Are statins to be STASHed in subarachnoid haemorrhage? [J]. Lancet Neurol, 2014, 13(7): 639-641.
27
Kirkpatrick PJ, Turner CL, Smith C, et al. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial [J]. Lancet Neurol, 2014, 13(7): 666-675.
28
Grasso G, Tomasello G, Noto M, et al. Erythropoietin for the treatment of subarachnoid hemorrhage: a feasible ingredient for a successful medical recipe [J]. Mol Med, 2015, 21(1): 979-987.
29
Grasso G, Tomasello F. Erythropoietin for subarachnoid hemorrhage: is there a reason for hope? [J]. World Neurosurg, 2012, 1(77): 46-48.
30
Helbok R, Shaker E, Beer R, et al. High dose erythropoietin increases brain tissue oxygen tension in severe vasospasm after subarachnoid hemorrhage [J]. BMC neurol, 2012, 12(1): 32.
31
Tseng MY, Hutchinson PJ, Richards HK, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial [J]. J Neurosurg, 2009, 111(1): 171-180.
32
Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion [J]. Lancet, 2005, 366(9488): 809-817.
33
Ruan C, Long H, Sun H, et al. Endovascular coiling vs. surgical clipping for unruptured intracranial aneurysm: a meta-analysis [J]. Br J Neurosurg, 2015, 29(4): 485-492.
34
Tomatis A, Trevisi G, Boido B, et al. Surgical outcomes and their correlation to increasing surgical experience in a series of 250 ruptured or unruptured aneurysm undergoing microsurgical clipping [J]. World Neurosurgery, 2019, 130: e542-e550.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 曹琮沅, 黄烁金, 何倩婷, 王安训. 平阳霉素复合剂治疗口腔颌面部脉管畸形的有效性和安全性[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 368-374.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[7] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[8] 中国抗癌协会, 中国抗癌协会大肠癌专业委员会. 中国恶性肿瘤整合诊治指南-肛管癌(2024 版)[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 441-449.
[9] 吴天宇, 刘子璇, 杨浦鑫, 贾思明, 丁凯, 程晓东, 李泳龙, 陈伟, 吕红芝, 张奇. 腰椎间盘突出症保守治疗进展[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 379-384.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
阅读次数
全文


摘要